共 212 条
[21]
Vijaya G(2017)Urinary nerve growth factor as a potential biomarker of treatment outcomes in overactive bladder patients Int Neurourol J 21 270-281
[22]
Cartwright R(2019)Urinary biomarkers of overactive bladder Chin Med J 132 1104-1106
[23]
Derpapas A(2015)NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome Yonsei Med J 56 204-211
[24]
Gallo P(2013)Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome PLoS One 8 e64696-330
[25]
Fernando R(2013)Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics Int Urogynecol J 24 325-2274
[26]
Khullar V(2008)Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder J Urol 179 2270-803
[27]
Kuo HC(2011)Urinary nerve growth factor in women with overactive bladder syndrome BJU Int 107 799-177
[28]
Antunes-Lopes T(2017)Potential biomarkers for diagnosis of overactive bladder patients: urinary nerve growth factor, prostaglandin E2, and adenosine triphosphate Int Neurourol J 21 171-8619
[29]
Antunes-Lopes R(2014)Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type a treatment: is there a clinical benefit? BMC Urol 14 85-409
[30]
Pinto SC(2014)Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis Genet Mol Res 13 8609-1794